Vanda Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -0.6% | -2.2% | +12.4% | -1.7% | +7.1% | -1.5% | +8.6% | +3.8% | +7.9% | -10.0% | +23.8% | +0.7% | +2.4% | -4.8% | +7.3% | -3.1% | +12.2% | -7.4% | +8.3% | +3.2% | -3.0% | -11.5% | +7.0% | +1.4% | -1.3% | -3.1% | -26.3% | -15.7% | +16.6% | +4.8% | +6.3% | -5.6% | +11.6% | -5.9% | +5.1% | +7.0% | +1.7% | -9.6% | -2.3% | – | |
| – | -24.6% | -24.1% | +13.1% | -0.1% | +5.9% | -4.8% | +14.3% | -2.8% | +11.8% | -9.8% | +24.5% | +6.5% | -8.2% | -16.4% | +12.3% | +0.9% | +8.7% | -6.0% | +8.9% | +3.5% | -8.3% | -9.2% | +7.0% | +4.3% | -1.3% | -23.5% | -26.7% | -12.5% | +13.0% | +57.7% | -17.8% | -43.1% | +1.5% | +35.9% | +27.4% | -34.2% | +29.8% | +34.3% | -30.8% | – | |
| – | +4.7% | +1.3% | +12.3% | -1.9% | +7.3% | -1.1% | +8.0% | +4.6% | +7.5% | -10.1% | +23.7% | +0.0% | +3.8% | -3.5% | +6.8% | -3.5% | +12.6% | -7.5% | +8.3% | +3.2% | -2.4% | -11.7% | +7.0% | +1.1% | -1.3% | -0.9% | -26.3% | -16.0% | +16.9% | +0.5% | +9.5% | -1.9% | +12.2% | -8.1% | +3.4% | +10.8% | +0.1% | -12.8% | +0.9% | – | |
| – | +4.4% | +38.8% | -27.6% | +33.1% | -0.2% | -7.3% | +4.8% | +15.4% | +13.5% | +2.8% | -17.5% | +3.6% | +15.2% | +18.8% | -16.9% | -4.7% | +20.7% | +8.6% | +25.5% | -2.9% | -1.6% | +8.5% | +2.5% | +15.7% | -25.8% | +4.2% | -13.5% | -0.3% | +46.6% | -13.1% | -21.2% | +0.7% | +18.3% | +80.0% | -38.4% | +2.6% | +28.6% | -2.0% | +30.0% | – | |
| – | +2.7% | +34.6% | +3.5% | -0.8% | -4.4% | -9.8% | +4.2% | -6.8% | -7.8% | +29.2% | +1.4% | -4.0% | +11.9% | +9.5% | -8.4% | +0.2% | -32.4% | +29.7% | -4.9% | +14.5% | -17.6% | +52.7% | -19.2% | -9.5% | +1.1% | +19.6% | -21.3% | -12.8% | -6.7% | +30.2% | +31.2% | -4.8% | -0.5% | +34.0% | +29.0% | -6.7% | +4.5% | +8.5% | +5.1% | – | |
| – | +4.6% | +22.9% | -4.5% | +5.8% | -0.2% | -12.1% | +4.5% | -1.0% | +1.0% | +16.9% | -4.2% | -2.0% | +20.3% | +4.9% | -10.8% | -1.1% | +8.8% | -8.8% | +5.8% | +7.2% | +1.3% | +17.0% | -11.8% | +0.4% | -6.3% | +8.0% | -18.5% | -8.1% | +17.1% | +4.8% | +9.6% | -0.1% | +8.5% | +49.6% | -4.9% | -2.3% | +10.8% | +3.3% | +14.4% | – | |
| – | – | – | – | – | – | – | +60.2% | +59.3% | +46.8% | -122.8% | – | +8.7% | -60.6% | -102.9% | – | -15.6% | +35.0% | -1.1% | +19.6% | -12.5% | -20.2% | -188.8% | – | +12.9% | +69.6% | -69.8% | -243.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +213.3% | +372.0% | +92.1% | +18.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | +53.4% | +54.5% | +42.1% | -105.8% | – | +6.3% | -52.7% | -78.6% | +793.6% | -24.2% | +30.0% | -4.5% | +20.9% | -14.9% | -19.7% | -187.9% | – | +44.1% | +76.0% | -42.5% | -53.1% | -104.6% | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -81.7% | -63.2% | +228.6% | +278.3% | -102.3% | – | +2.2% | -145.7% | – | +80.0% | -489,805.6% | – | -52.6% | +214.6% | +3.3% | +11.4% | -35.0% | +66.0% | +0.0% | -48.1% | -174.0% | – | +80.2% | +25.6% | -17.3% | -52.9% | -124.0% | – | -170.1% | – | – | – | – | – | – | – | -99.9% | -9.8% | – | |
| – | – | – | – | – | – | – | +50.4% | +55.5% | +44.5% | -105.9% | – | +771.3% | -95.8% | -88.5% | +1,693.0% | -31.8% | +37.7% | +5.6% | +11.6% | -19.5% | -8.9% | -190.8% | – | +27.0% | +109.8% | -52.6% | -53.3% | -91.0% | -1,851.8% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -31.0% | -515.8% | – | – | – | – | +48.5% | +49.6% | +41.8% | -117.2% | – | +6.0% | -61.7% | -88.0% | +1,558.2% | -14.4% | +37.6% | -5.0% | +20.4% | -14.2% | -18.5% | -173.7% | – | +37.0% | +67.4% | -39.7% | -48.5% | -85.6% | -209.3% | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.